S. Jones

发表

Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis

J. Parry, T. Rhodes, A. Renton, 2005, Journal of viral hepatitis.

Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

J. Parry, M. Hickman, O. Gill, 2001, American journal of public health.

Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England.

M. Hickman, G. Stimson, A. Judd, 2000, Addiction.

A short questionnaire (IRQ) to assess injecting risk behaviour.

G. Stimson, C. Chalmers, S. Jones, 1998, Addiction.

Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales.

G. Stimson, Steve Jones, N. Parry-Langdon, 1993, Addiction.

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots

J. Parry, M. Hickman, Steve Jones, 2011, Journal of viral hepatitis.

Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004

V. Hope, P. Madden, M. Hickman, 2007, Journal of viral hepatitis.

Prevalence of HIV infection in a multi-site sample of injecting drug users not in contact with treatment services in England.

J. Parry, M. Hickman, G. Stimson, 2000, AIDS.

Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study

S. Jones, Tyler Marshall, Julia Kim, 2023, Harm Reduction Journal.

Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study

S. Jones, Barbara Fornssler, S. M. Ghosh, 2023, Harm Reduction Journal.